Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
24.07
+1.08 (4.70%)
At close: Mar 4, 2026, 4:00 PM EST
24.24
+0.17 (0.71%)
After-hours: Mar 4, 2026, 7:42 PM EST
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
The 14 analysts that cover Acadia Healthcare Company stock have a consensus rating of "Buy" and an average price target of $21.64, which forecasts a -10.10% decrease in the stock price over the next year. The lowest target is $13 and the highest is $30.
Price Target: $21.64 (-10.10%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Acadia Healthcare Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 4 | 4 | 5 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 5 | 6 | 5 | 6 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $14 → $20 | Hold | Maintains | $14 → $20 | -16.91% | Mar 3, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $14 → $22 | Hold | Maintains | $14 → $22 | -8.60% | Feb 26, 2026 |
| UBS | UBS | Strong Buy Maintains $24 → $27 | Strong Buy | Maintains | $24 → $27 | +12.17% | Feb 26, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | -0.29% | Feb 26, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $28 | Buy | Maintains | $17 → $28 | +16.33% | Feb 26, 2026 |
Financial Forecast
Revenue This Year
3.49B
from 3.31B
Increased by 5.23%
Revenue Next Year
3.69B
from 3.49B
Increased by 5.97%
EPS This Year
1.50
from -12.16
EPS Next Year
1.73
from 1.50
Increased by 15.38%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 3.6B | 3.9B | ||
| Avg | 3.5B | 3.7B | ||
| Low | 3.3B | 3.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 10.1% | 12.4% | ||
| Avg | 5.2% | 6.0% | ||
| Low | 0.2% | -0.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 1.70 | 1.95 | ||
| Avg | 1.50 | 1.73 | ||
| Low | 1.19 | 1.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | 30.0% | ||
| Avg | - | 15.4% | ||
| Low | - | 1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.